1. Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials. Issue 2 (26th November 2019) Authors: Davidson, J. A.; Desouza, C.; Fonseca, V.; Frias, J. P.; Van Gaal, L.; Giorgino, F.; Chao, J.; Dex, T. A.; Roberts, M.; Saremi, A.; Leiter, L. A. Journal: Diabetic medicine Issue: Volume 37:Issue 2(2020) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗